US2023183276A1PendingUtilityA1
Pyrrole inhibitors of erk protein kinase, synthesis thereof and intermediates thereto
Est. expiryMay 14, 2024(expired)· nominal 20-yr term from priority
A61P 35/00A61P 43/00A61P 31/12A61P 1/04A61P 37/00A61P 1/16A61P 35/02A61P 9/10C07F 9/65583A61P 37/02C07D 401/04A61P 37/06A61P 1/18A61P 29/00A61P 37/04A61P 15/00A61P 25/00A61P 19/08A61P 9/00A61P 17/00
82
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to compounds useful of inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
Claims
exact text as granted — not AI-modified1 .- 9 . (canceled)
10 . The compound
11 . A composition comprising a compound according to claim 10 and a pharmaceutically acceptable carrier, adjuvant, or vehicle.
12 . A pharmaceutically acceptable salt of the compound
13 . A composition comprising the pharmaceutically acceptable salt of the compound according to claim 12 and a pharmaceutically acceptable carrier, adjuvant, or vehicle.Join the waitlist — get patent alerts
Track US2023183276A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.